RT @DrJoMorrison1: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy - Rutjes, AWS - 2020…
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy - Rutjes, AWS - 2020 | Cochrane Library @Adeola0A discussing VTE prophylaxis in patients on NACT for ovarian treatment #bgcs2022 @BGCS_org https://t.co
RT @CochraneIberoam: 🎙 Nuevo #Podcast : Prevención de los coágulos de sangre en pacientes con cáncer no hospitalizados que reciben #quimiot…
RT @CochraneIberoam: 🎙 Nuevo #Podcast : Prevención de los coágulos de sangre en pacientes con cáncer no hospitalizados que reciben #quimiot…
🎙 Nuevo #Podcast : Prevención de los coágulos de sangre en pacientes con cáncer no hospitalizados que reciben #quimioterapia Puedes escucharlo aquí 👉🏽 : https://t.co/oMrkQHS70O O leer la revisión completa👇 https://t.co/LJsdgH9C9R #revisiónsistemática #cán
RT @CochraneUK: Listen to this new @CochraneLibrary podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving…
RT @CochraneUK: A new @CochraneLibrary podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherap…
RT @CochraneUK: A new @CochraneLibrary podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherap…
RT @CochraneUK: Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receivin…
RT @ParsonageMaria: Prevention of blood clots in non-hospitalised #cancer patients receiving chemotherapy https://t.co/M6zOWJVekO
Prevention of blood clots in non-hospitalised #cancer patients receiving chemotherapy https://t.co/yDSA7bMEbD
Prevention of blood clots in non-hospitalised #cancer patients receiving chemotherapy https://t.co/T5V38CVV6d
Prevention of blood clots in non-hospitalised #cancer patients receiving chemotherapy https://t.co/M6zOWJVekO
RT @CochraneUK: Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receivin…
RT @Wiley_Health: Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiv…
Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy. The featured @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/Z67KU2
RT @Wiley_Nursing: Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients recei…
Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy. The featured @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/GncQWlFXCL
RT @WileyOnc_Hem: Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiv…
Listen to this new @CochraneLibrary #Podcast on the prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy. The featured @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/CbGJq4
RT @cochranecollab: #CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneV…
RT @cochranecollab: #CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneV…
Prevention of blood clots in non-hospitalised cancer patients receiving chemotherapy | Cochrane https://t.co/ZBVE1YcMA5
#CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/A9qjVcuyDE
RT @CochraneUK: #CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneVasc…
#CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/AS2WEqtEra
#CochranePodcast - Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy - @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants. https://t.co/0H5gLuQ0zS
部内ジャーナルクラブのネタ探し。 次回はコクランレビューを読む会。
外来化学療法中の予防抗凝固、コクランレビュー。 VTEへる。出血増える。不思議はない。 Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy - Rutjes, AWS - 2020 | Cochrane Library https://t.co/nbBM0lfmj6
RT @CochraneUK: Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy: https://t.co/70uJ1Bn3ug New @Cochra…
RT @CochraneUK: Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy: https://t.co/70uJ1Bn3ug New @Cochra…
RT @CochraneUK: Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy: https://t.co/70uJ1Bn3ug New @Cochra…
RT @CochraneVasc: New @CochraneVasc update Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy includes…
New @CochraneVasc update Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy includes 32 RCTs involving 15,678 participants https://t.co/lcdGDAX8yj @VSGBI @isth @VeinForum @AnticoagForum @ThrombosisUK https://t.co/ZL2TrBk
RT @CochraneVasc: New @CochraneVasc update Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy includes…
New @CochraneVasc update Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy includes 32 RCTs involving 15,678 participants https://t.co/5A4FJ4tDtH @VSGBI @isth @VeinForum @AnticoagForum @ThrombosisUK https://t.co/ex7X7n3
Cochrane Review: Primary prophylaxis for venous thromboembolism in ambulatory #cancer patients receiving chemotherapy https://t.co/gGKASRrS48
Academic correctness within some Cochrane Reviews – a double-edge sword – more rigour, but rather bland too...? https://t.co/q4b7BUixJx https://t.co/rUj5J2ao4u
Prevention of #bloodclots in non‐hospitalised #cancer patients receiving #chemotherapy https://t.co/qKIopO6mUk New @CochraneVasc systematic review includes 32 RCTs involving 15,678 participants.
(Cochrane) Profilaxis primaria de tromboembolismo venoso en pacientes oncológicos ambulatorios en tratamiento con quimioterapia. Mayor evidencia con HBPM y con inhibidores directos del factor Xa. Precaución por el riesgo de sangrado. https://t.co/FUFNPsWnI
New article: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. https://t.co/k0iPGkyH4d #MMSM #MultipleMyeloma #hematology https://t.co/poBwHg5GdH